Exploring Current and Investigational Mechanisms of Action in Treating Geographic Atrophy

Experts will discuss the mechanism of action of current and investigational complement inhibitors, including the rationale for their use and differences between them (eg, targeted proteins). Discussion will also review treatment approaches under investigation, such as neuroprotective treatments, gene therapies, and cell-based therapies, and whether there may be a rationale in eventually combining any treatments.

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at ketrea@akhcme.com